Pharmacokinetic–Pharmacometabolomic Approach in Early-Phase Clinical Trials: A Way Forward for Targeted Therapy in Type 2 Diabetes
Pharmacometabolomics in early phase clinical trials demonstrate the metabolic profiles of a subject responding to a drug treatment in a controlled environment, whereas pharmacokinetics measure the drug plasma concentration in human circulation. Application of the personalized peak plasma concentrati...
Main Authors: | Khim Boon Tee, Luqman Ibrahim, Najihah Mohd Hashim, Mohd Zuwairi Saiman, Zaril Harza Zakaria, Hasniza Zaman Huri |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/14/6/1268 |
Similar Items
-
Pharmacometabolomics of trabectedin in metastatic soft tissue sarcoma patients
by: Giuseppe Corona, et al.
Published: (2023-08-01) -
Pharmacokinetics and Metabolomic Profiling of Metformin and <i>Andrographis paniculata</i>: A Protocol for a Crossover Randomised Controlled Trial
by: Khim Boon Tee, et al.
Published: (2022-07-01) -
A temporo-spatial pharmacometabolomics method to characterize pharmacokinetics and pharmacodynamics in the brain microregions by using ambient mass spectrometry imaging
by: Dan Liu, et al.
Published: (2022-08-01) -
Pharmacokinetics in Pharmacometabolomics: Towards Personalized Medication
by: Jingai Jian, et al.
Published: (2023-11-01) -
Pharmacometabolomics Profiling of Preterm Infants Validates Patterns of Metabolism Associated With Response to Dexamethasone Treatment for Bronchopulmonary Dysplasia
by: Bradley Stockard, et al.
Published: (2022-06-01)